skip to content
Systematic Reviews of Treatments for Lymphoma
Follow the links below to find summaries of systematic reviews of the evidence for the effectiveness of treatments for lymphoma.
Created July 2011
13 Resources Found
Results 1 to 13 displayed.
| Title: | Treatment of early stage Hodgkin lymphoma |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Hodgkin lymphoma is a malignancy of the lymphatic system, first described by Thomas Hodgkin. It can occur in children and adults, but it is more common in the third decade of life. It is one of the most curable forms of cancer. Clinically speaking, ther... |
| Date: | Jan 2011 |
| Title: | Therapeutic interventions for Burkitt lymphoma in children |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Burkitt lymphoma is an important cancer, particularly in children. It is a fast growing tumour but also very sensitive to chemotherapy. It presents a challenge in endemic areas due to late presentation and an often incomplete complement of drugs availab... |
| Date: | Jan 2011 |
| Title: | Comparison of the two international standards of chemotherapy for patients with early unfavourable or advanced stage Hodgkin lymphoma |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Hodgkin lymphoma is a malignancy of the lymphatic system. It is one of the most common cancers in young adults, particularly in their third decade of life, but it occurs also in children and elderly people. Within the last fifty years it has become one ... |
| Date: | Aug 2010 |
| Title: | High-dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive Non-Hodgkin Lymphoma (NHL) in adults |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Aggressive Non-Hodgkin's Lymphomas (NHLs) are fast growing forms of lymphoma. The most common type is a diffuse large B-Cell lymphoma (DLCL) but there are several other subtypes of aggressive lymphoma and variants of DLCL, such as centroblastic, immunob... |
| Date: | Jun 2010 |
| Title: | Rituximab as maintenance therapy for patients with follicular lymphoma |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Follicular lymphoma is a B-cell lymphoma characterised by an initial response to treatment that is usually followed by relapse and progression. Most patients present with advanced disease that cannot be cured. Lymphoma B-cells express CD20. Rituximab, a... |
| Date: | Feb 2009 |
| Title: | Bisphosphonates in multiple myeloma |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Multiple myeloma (also known as myeloma or plasma cell myeloma) is a B-cell malignancy, or more precisely, plasma cell neoplasm. Multiple myeloma cells migrate to the bone marrow and continuously multiply. Thus, the cancer grows inside or outside of the... |
| Date: | Jan 2009 |
| Title: | Interferon-alpha in the maintenance therapy of follicular non-Hodgkin's lymphoma |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | The aim of this systematic review is to outline the possible benefits (i.e. prolonging survival) and also the disadvantages (adverse events) of therapy with interferon-alpha, administered alone or in combination with other proven drug regimens (otherwis... |
| Date: | Dec 2008 |
| Title: | Granulopoiesis-stimulating factors in the prevention of adverse effects during the therapeutic treatment of malignant lymphoma. |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Lymphoma is a cancer that begins in the lymph nodes. It can be treated with chemotherapy (anti-cancer drugs), but this disrupts the immune system and lowers white cell counts. This can increase a person's risk of infection and limit the amount of chemot... |
| Date: | Apr 2008 |
| Title: | Interventions for untreated patients with AIDS-associated non-Hodgkin's lymphoma |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Lymphoma is a cancer of the lymphatic system. There are two general types: Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL). Non-Hodgkin's lymphoma is the most common AIDS-defining malignancy in HIV-infected patients. The most frequent clinical p... |
| Date: | Jan 2008 |
| Title: | Although the addition of the anti-CD20 monoclonal antibody rituximab to chemotherapy (R-chemo) has been shown to improve response rates and progression-free survival in patients with indolent or mantle cell lymphoma, the efficacy of R-chemo with respect t |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Study design: Meta-analysis of seven randomised controlled trials involving 1943 patients.Contribution: Patients treated with R-chemo had better overall survival, overall response, complete response, and disease control but more leukocytopenia and fever... |
| Date: | Aug 2007 |
| Title: | Interventions for previously untreated AIDS-associated Hodgkin's lymphoma in adults |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | There is a lack of evidence from randomised controlled trials for the efficacy and safety of different interventions for treating AIDS-associated Hodgkin's disease, regarding both overall survival and disease-free survival in treatment-naive adults with... |
| Date: | Feb 2007 |
| Title: | Second malignancy risk in Hodgkin's disease patients depends upon the choice of chemotherapy and/or radiotherapy as first-line treatment. |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Hodgkin's disease (HD) patients are usually treated initially with radiotherapy alone (RT; early stages only), chemotherapy alone (CT) or combined chemo-radiotherapy (CRT). A meta-analysis of data from 37 randomised trials including over 9000 patients w... |
| Date: | Aug 2005 |
| Title: | Early treatment for early stage multiple myeloma may slow the disease progression but does not appear to improve survival |
|---|---|
| Publisher: | John Wiley and Sons, Ltd. for The Cochrane Collaboration |
| Description: | Multiple myeloma (MM) is cancer of the bone marrow. It causes bone destruction that leads to pain, spinal cord compression and fractures.In early stages, most people do not show any symptoms of MM. It is not clear whether it is better to start treatment... |
| Date: | Nov 2002 |
Results 1 to 13 displayed.
